Industry News

Dec 10, 2018
By Pharmaceutical Technology Editors
The companies aim to advance research into inflammatory bowel disease.
Dec 05, 2018
By Pharmaceutical Technology Editors
Shire has announced that the European Commission has granted marketing authorisation for Takhzyro (lanadelumab) subcutaneous injection.
Dec 05, 2018
By Pharmaceutical Technology Editors
The UK's government has revealed the details of the second Life Sciences sector deal, forming part of the Industrial Strategy.
Dec 05, 2018
By Pharmaceutical Technology Editors
Novartis has announced that the European Commission has approved Gilenya (fingolimod) as a treatment for children and adolescents (10–17 years) with relapsing-remitting forms of multiple sclerosis (RRMS).
Dec 05, 2018
By Pharmaceutical Technology Editors
NICE has recommended the use of regorafenib as a treatment for NHS patients with advanced liver cancer, following consideration of a new commercial arrangement.
Dec 05, 2018
By Pharmaceutical Technology Editors
The EMA has published a revision to its guideline on the environmental risk assessment of human medicines.
Dec 03, 2018
The proposal from the Centers for Medicare and Medicaid Services (CMS) proposes to give plans more flexibility to limit coverage of certain drugs.
Nov 30, 2018
By Pharmaceutical Technology Editors
Five additional European Union member states have been confirmed by the US Food and Drug Administration (FDA) as capable of performing good manufacturing practice inspections at a level equivalent to that of the United States.
Nov 30, 2018
By Pharmaceutical Technology Editors
In a strategic move to strengthen its core life science businesses, Bayer announces 900 R&D and 350 manufacturing job cuts.
Nov 29, 2018
Despite ongoing efforts to address the problem, FDA now sees a rise in active shortages and in the duration of supply problems.
native1_300x100
lorem ipsum